Related Articles
HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells
Clinical implications of hypoxia‑inducible factor‑1α and caveolin‑1 overexpression in isocitrate dehydrogenase‑wild type glioblastoma multiforme
Hsp90 inhibition by WK88-1 potently suppresses the growth of gefitinib-resistant H1975 cells harboring the T790M mutation in EGFR
The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)